Stock analysts at StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) in a research note issued on Tuesday. The firm set a “hold” rating on the biotechnology company’s stock.
Bellerophon Therapeutics Price Performance
NASDAQ:BLPH opened at $0.05 on Tuesday. The company’s 50 day moving average is $0.05 and its 200-day moving average is $0.05. The firm has a market cap of $627,399.00, a price-to-earnings ratio of -0.06 and a beta of 0.67. Bellerophon Therapeutics has a 12 month low of $0.03 and a 12 month high of $11.15.
About Bellerophon Therapeutics
Further Reading
- Five stocks we like better than Bellerophon Therapeutics
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- AMD is Down 35%. Now is the Time to Buy the Dip
- Do ETFs Pay Dividends? What You Need to Know
- Amazon Stands Tall: New Highs Are in Sight
- Options Trading – Understanding Strike Price
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
